Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

249

Figures (1-10)

Tables (1-6)

Sum=368

Publishing Process of This Article

Item

Count

Browse

Download

Sum=61

Aug 26, 2024 (publication date) through Sep 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Aug 26, 2024; 12(24): 5568-5582
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5568

Table 4 Binding energy between EZH2 and four chemotherapy drugs in molecular docking

PDB ID: Protein database ID.

Citation: Yu TY, Zhan ZJ, Lin Q, Huang ZH. Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma. World J Clin Cases 2024; 12(24): 5568-5582
URL: https://www.wjgnet.com/2307-8960/full/v12/i24/5568.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i24.5568